Postoperative Pain Comparison Between Alcohol-Assisted and Transepithelial Photorefractive Keratectomy Using Nepafenac Treatment: A Novel Study.
Analgetic
Nepafenac
Nevanac
Nonsteroidal antiinflammatory drug (NSAID)
Pain
Photorefractive keratectomy (PRK)
Postoperative adverse events
Refractive surgery
Journal
Ophthalmology and therapy
ISSN: 2193-8245
Titre abrégé: Ophthalmol Ther
Pays: England
ID NLM: 101634502
Informations de publication
Date de publication:
03 Oct 2024
03 Oct 2024
Historique:
received:
04
08
2024
accepted:
16
09
2024
medline:
4
10
2024
pubmed:
4
10
2024
entrez:
3
10
2024
Statut:
aheadofprint
Résumé
The study aimed to compare postoperative pain between alcohol-assisted and transepithelial photorefractive keratectomy in patients who received the novel analgesic preoperative nepafenac treatment 2 days preoperatively and 3 days postoperatively. Pain, stinging, tearing, light sensitivity, and stress levels were evaluated. The study included a retrospective analysis of 55 patients divided into two groups: bilateral alcohol-assisted photorefractive keratectomy (aa-PRK) and transepithelial photorefractive keratectomy (transepithelial-PRK). Nepafenac was administered for pain control for all patients, with patients receiving four drops for 2 days before the surgery and 3 days postoperatively per clinical instructions. Patients completed questionnaires on the day of the surgery and for the first 5 days postoperatively. Statistical analysis was performed using XLSTAT (version 2023.1.2). t-Test was used to analyze and compare pain and symptom levels and Fisher's exact test for categorical data. p-Values less than 0.05 were considered statistically significant. The study examined 55 patients (49% female) with a mean age of 25.11 ± 6.81 years who had undergone bilateral surface refractive surgery to correct myopic errors. The mean baseline standard error (SE) was -3.16 ± 2.20 D. Among these patients, 27 patients underwent aa-PRK and 28 patients underwent transepithelial-PRK. Higher levels of pain were significant in the aa-PRK group (p = 0.003). However, there was no significant difference between the groups in the average levels of stinging, tearing, or light sensation. Additionally, stress levels decreased over time in both groups, with levels becoming almost equal after 5 days, and there was no significant difference in the average stress levels between the two groups. The study found that patients who underwent the transepithelial-PRK procedure had significantly lower pain levels compared with those who underwent aa-PRK after being treated with nepafenac per protocol. However, there was no significant difference between the two groups in terms of stinging, tearing, light sensation, and stress levels.
Identifiants
pubmed: 39363130
doi: 10.1007/s40123-024-01040-8
pii: 10.1007/s40123-024-01040-8
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2024. The Author(s).
Références
Achiron A, Gur Z, Aviv U, Hilely A, Mimouni M, Karmona L, et al. Predicting refractive surgery outcome: machine learning approach with big data. J Refract Surg. 2017;33:592–7. https://doi.org/10.3928/1081597X-20170616-03 .
doi: 10.3928/1081597X-20170616-03
pubmed: 28880333
Hamam KM, Gbreel MI, Elsheikh R, Benmelouka AY, Ouerdane Y, Hassan AK, et al. Outcome comparison between wavefront-guided and wavefront-optimized photorefractive keratectomy: a systematic review and meta-analysis. Indian J Ophthalmol. 2020;68:2691–8. https://doi.org/10.4103/ijo.IJO_2921_20 .
doi: 10.4103/ijo.IJO_2921_20
pubmed: 33229644
pmcid: 7856933
Zhang H, Li M, Cen Z. Excimer laser corneal refractive surgery in the clinic: a systematic review and meta-analysis. Comput Math Methods Med. 2022;2022:7130422. https://doi.org/10.1155/2022/7130422 .
doi: 10.1155/2022/7130422
pubmed: 35756422
pmcid: 9217613
Ang M, Gatinel D, Reinstein DZ, Mertens E, Alió del Barrio JL, Alió JL. Refractive surgery beyond 2020. Eye. 2021;35:362–82. https://doi.org/10.1038/s41433-020-1096-5 .
doi: 10.1038/s41433-020-1096-5
pubmed: 32709958
Rodriguez AH, Galvis V, Tello A, Parra MM, Rojas MÁ, Arba MS, et al. Fellow eye comparison between alcohol-assisted and single-step transepithelial photorefractive keratectomy: late mid-term outcomes. Rom J Ophthalmol. 2020;64:176–83.
doi: 10.22336/rjo.2020.30
pubmed: 32685784
pmcid: 7339690
McDonnell PJ, Moreira H, Clapham TN. Photorefractive keratectomy for astigmatism. Initial clinical results. Arch Ophthalmol. 1991;109:1370–3.
doi: 10.1001/archopht.1991.01080100050041
pubmed: 1929923
Sorkin N, Perez MA, Rootman DS. Excimer laser surface treatment: photorefractive keratectomy. In: Mannis MJ, Holland EJ, editors. Cornea: fundamentals, diagnosis and management. 5th ed. Amsterdam: Elsevier; 2022. p. 1682–94.
Duvdevan N, Mimouni M, Dominitz Y, Sela T, Munzer G, Achiron A, et al. Flap protection during laser-assisted in situ keratomileusis improves refractive outcomes in high myopic astigmatism. Clin Exp Vis Eye Res. 2019;2:11–7. https://doi.org/10.15713/ins.clever.22 .
doi: 10.15713/ins.clever.22
Stern C. New refractive surgery procedures in ophthalmology and the influence on Pilot’s fitness for flying. Eur J Med Res. 1999;4:382–4.
pubmed: 10477505
Skevas C, Katz T, Wagenfeld L, Richard G, Linke S. Subjective pain, visual recovery and visual quality after LASIK, EpiLASIK (flap off) and APRK—a consecutive, non-randomized study. Graefe’s Arch Clin Exp Ophthalmol. 2013;251:1175–83. https://doi.org/10.1007/s00417-012-2181-7 .
doi: 10.1007/s00417-012-2181-7
Tomás-Juan J, Murueta-Goyena Larrañaga A, Hanneken L. Corneal regeneration after photorefractive keratectomy: a review. J Optom. 2015;8:149–69. https://doi.org/10.1016/j.optom.2014.09.001 .
doi: 10.1016/j.optom.2014.09.001
pubmed: 25444646
Golan O, Randleman JB. Pain management after photorefractive keratectomy. Curr Opin Ophthalmol. 2018;29:306–12. https://doi.org/10.1097/ICU.0000000000000486 .
doi: 10.1097/ICU.0000000000000486
pubmed: 29708926
Müller LJ, Marfurt CF, Kruse F, Tervo TMT. Corneal nerves: structure, contents and function. Exp Eye Res. 2003;76:521–42. https://doi.org/10.1016/S0014-4835(03)00050-2 .
doi: 10.1016/S0014-4835(03)00050-2
pubmed: 12697417
Rodrigues EB, Farah ME, Bottós JM, Aggio FB. Nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of retinal diseases. Retin Pharmacother. 2010. https://doi.org/10.1016/B978-1-4377-0603-1.00034-X .
doi: 10.1016/B978-1-4377-0603-1.00034-X
Gaeckle HC. Early clinical outcomes and comparison between trans-PRK and PRK, regarding refractive outcome, wound healing, pain intensity and visual recovery time in a real-world setup. BMC Ophthalmol. 2021;21:181. https://doi.org/10.1186/s12886-021-01941-3 .
doi: 10.1186/s12886-021-01941-3
pubmed: 33863311
pmcid: 8052644
Hashemi H, Alvani A, Aghamirsalim M, Miraftab M, Asgari S. Comparison of transepithelial and conventional photorefractive keratectomy in myopic and myopic astigmatism patients: a randomized contralateral trial. BMC Ophthalmol. 2022;22:68. https://doi.org/10.1186/s12886-022-02293-2 .
doi: 10.1186/s12886-022-02293-2
pubmed: 35148689
pmcid: 8832736
Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798–804. https://doi.org/10.1111/j.1365-2702.2005.01121.x .
doi: 10.1111/j.1365-2702.2005.01121.x
pubmed: 16000093
Zarei-Ghanavati S, Shandiz JH, Abrishami M, Karimpour M. Comparison of mechanical debridement and trans-epithelial myopic photorefractive keratectomy: a contralateral eye study. J Curr Ophthalmol. 2019;31:135–41. https://doi.org/10.1016/j.joco.2019.01.003 .
doi: 10.1016/j.joco.2019.01.003
pubmed: 31317090
pmcid: 6611919
Hashemi H, Alvani A, Aghamirsalim M, Miraftab M, Asgari S. Comparison of transepithelial and conventional photorefractive keratectomy in myopic and myopic astigmatism patients: a randomized contralateral trial. BMC Ophthalmol. 2022;22(1):68. https://doi.org/10.1186/s12886-022-02293-2 . (published 2022 Feb 11).
doi: 10.1186/s12886-022-02293-2
pubmed: 35148689
pmcid: 8832736
Gharieb HM, Awad-Allah MAA, Ahmed AA, Othman IS. Transepithelial laser versus alcohol assisted photorefractive keratectomy safety and efficacy: 1-year follow-up of a contralateral eye study. Korean J Ophthalmol. 2021;35:142–52. https://doi.org/10.3341/kjo.2020.0105 .
doi: 10.3341/kjo.2020.0105
pubmed: 33596623
pmcid: 8046614
Donnenfeld ED, Holland EJ, Durrie DS, Raizman MB. Double-masked study of the effects of nepafenac 0.1% and ketorolac 0.4% on corneal epithelial wound healing and pain after photorefractive keratectomy. Adv Ther. 2007;24:852–62. https://doi.org/10.1007/BF02849978 .
doi: 10.1007/BF02849978
pubmed: 17901034